Rambam Health Care Campus in Israel will launch in collaboration with Technion/Israel Institute of Technology a phase I clinical trial about “personalized medicine in diabetes using a nanotechnology platform”, registered in the Clinicaltrials.gov database under reference NCT01268813. In this trial, breath samples will be collected in inert respiratory bag from diabetic and healthy volunteers, and analyzed using a chamber containing nano-chemical sensors. These samples together with blood samples will additionally be characterized using Gas Chromatography-Mass Spectroscopy (GC-MS). The study is not yet open for participant recruitment.
Posted on January 23, 2011 by nanocolors